<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is one of the leading causes of mortality in the western world </plain></SENT>
<SENT sid="1" pm="."><plain>It is widely accepted that <z:hpo ids='HP_0002664'>neoplasms</z:hpo> such as <z:mp ids='MP_0003269'>colonic polyps</z:mp> are precursors to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> formation; with the <z:mpath ids='MPATH_491'>polyp</z:mpath>-<z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequences well described in medical literature [1, 2] </plain></SENT>
<SENT sid="2" pm="."><plain>It has been shown that Aspirin and other non-steroid <z:chebi fb="3" ids="35472">anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAID</z:chebi>) have a negative effect on <z:mpath ids='MPATH_491'>polyp</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> formation </plain></SENT>
<SENT sid="3" pm="."><plain>This review aims to describe some of the mechanism behind the chemoprotective properties of aspirin; COX 2 inhibition, regulation of proliferation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and effects on the immune system and also the current evidence that supports its use as a chemoprevention agent against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We will also aim to explore the side effects with the use of aspirin and the pitfalls of using aspirin routinely for primary prophylaxis against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>